March 28, 2024

Surgical Sphincteroplasty Market Size to Record US$ 5.67 billion by 2030

The global surgical sphincteroplasty market size was valued at USD 2.3 billion in 2020, and is predicted to be worth around USD 5.67 billion by 2030, registering a CAGR of 6.8% during the forecast period 2022 to 2030.

Surgical Sphincteroplasty Market (By Type: Surgical (sphincteroplasty), Non-Surgical) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39094

Report Coverage

Report ScopeDetails
Market SizeUS$ 5.67 billion by 2030
Growth RateCAGR of 6.8% From 2022 to 2030
Largest MarketNorth America
Base Year2021
Forecast Period2022 to 2030
Segments CoveredType

Growth Factors

The growing prevalence of Anal Incontinence (AI), cost-effectiveness of sphincteroplasty, and rising incidence of obstetric injury post-childbirth are the key factors driving the market. Anal Incontinence (AI) is a chronic condition that affects one out of every three individuals, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Additionally, studies suggest that AI affects nearly 15% of women living in the community and half of the women in nursing homes. Factors such as age, obstetric trauma, pelvic surgery, chronic diarrhea, obesity, and other medical conditions, such as diabetes and stroke, increase the risk of Al.

The growing prevalence of anal incontinency (AI), increasing frequency of obstetric injury after childbirth, rise in innovative techniques to treat AI, and growing clinical studies are the key contributing factors propelling the growth of the market. Presence of fewer market players makes this a less competitive market. However, to strengthen their market position they are constantly involved in adopting developmental strategies like collaboration and acquisition with other market players.

Key Players

  • Medtronic
  • Hill-Rom Services, Inc.
  • McKesson
  • B. Braun
  • Becton, Dickinson and Company
  • Novo Surgical, Inc.
  • Surgical Holdings
  • Pelvalon
  • Salix Pharmaceutical Inc.
  • Johnson & Johnson

Market Segmentation

  • By Type
    • Surgical (sphincteroplasty)
      • Direct apposition sphincteroplasty
      • Overlapping sphincteroplasty
    • Non-Surgical
      • Sacral nerve stimulation
      • Vaginal balloon inserts
      • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39094

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2019-2021) and forecast (2022-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Surgical Sphincteroplasty Market, By Type

7.1.  Surgical Sphincteroplasty Market, by Type, 2021-2030

7.1.1.    Surgical (sphincteroplasty)

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Non-Surgical

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Surgical Sphincteroplasty Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, by Type (2017-2030)

8.1.2.    U.S.

8.1.3.    Rest of North America

8.1.3.1.        Market Revenue and Forecast, by Type (2017-2030)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, by Type (2017-2030)

8.2.2.    UK

8.2.2.1.        Market Revenue and Forecast, by Type (2017-2030)

8.2.3.    France

8.2.3.1.        Market Revenue and Forecast, by Type (2017-2030)

8.2.4.    Rest of Europe

8.2.4.1.        Market Revenue and Forecast, by Type (2017-2030)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, by Type (2017-2030)

8.3.2.    India

8.3.2.1.        Market Revenue and Forecast, by Type (2017-2030)

8.3.3.    China

8.3.3.1.        Market Revenue and Forecast, by Type (2017-2030)

8.3.4.    Japan

8.3.4.1.        Market Revenue and Forecast, by Type (2017-2030)

8.3.5.    Rest of APAC

8.3.5.1.        Market Revenue and Forecast, by Type (2017-2030)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, by Type (2017-2030)

8.4.2.    GCC

8.4.2.1.        Market Revenue and Forecast, by Type (2017-2030)

8.4.3.    North Africa

8.4.3.1.        Market Revenue and Forecast, by Type (2017-2030)

8.4.4.    South Africa

8.4.4.1.        Market Revenue and Forecast, by Type (2017-2030)

8.4.5.    Rest of MEA

8.4.5.1.        Market Revenue and Forecast, by Type (2017-2030)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, by Type (2017-2030)

8.5.2.    Brazil

8.5.2.1.        Market Revenue and Forecast, by Type (2017-2030)

8.5.3.    Rest of LATAM

8.5.3.1.        Market Revenue and Forecast, by Type (2017-2030)

Chapter 9.    Company Profiles

9.1.  Medtronic

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  Hill-Rom Services, Inc.

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  McKesson

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  B. Braun

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  Becton, Dickinson and Company

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  Novo Surgical, Inc.

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

9.7.  Surgical Holdings

9.7.1.    Company Overview

9.7.2.    Product Offerings

9.7.3.    Financial Performance

9.7.4.    Recent Initiatives

9.8.  Pelvalon

9.8.1.    Company Overview

9.8.2.    Product Offerings

9.8.3.    Financial Performance

9.8.4.    Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39094

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →